Literature DB >> 23453713

The multiple facets of opioid receptor function: implications for addiction.

Pierre-Eric Lutz1, Brigitte L Kieffer.   

Abstract

Addiction is characterized by altered reward processing, disrupted emotional responses and poor decision-making. Beyond a central role in drug reward, increasing evidence indicate that opioid receptors are broadly involved in all these processes. Recent studies establish the mu opioid receptor as a main player in social reward, which attracts increasing attention in psychiatric research. There is growing interest in blocking the kappa opioid receptor to prevent relapse, and alleviate the negative affect of withdrawal. The delta opioid receptor emerges as a potent mood enhancer, whose involvement in addiction is less clear. All three opioid receptors are likely implicated in addiction-depression comorbidity, and understanding of their roles in cognitive deficits associated to drug abuse is only beginning.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23453713      PMCID: PMC3702666          DOI: 10.1016/j.conb.2013.02.005

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  63 in total

1.  Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption.

Authors:  Elyssa B Margolis; Howard L Fields; Gregory O Hjelmstad; Jennifer M Mitchell
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

2.  Quantitative autoradiography of mu-,delta- and kappa1 opioid receptors in kappa-opioid receptor knockout mice.

Authors:  S J Slowe; F Simonin; B Kieffer; I Kitchen
Journal:  Brain Res       Date:  1999-02-13       Impact factor: 3.252

Review 3.  Opiates as antidepressants.

Authors:  Esther Berrocoso; Pilar Sánchez-Blázquez; Javier Garzón; Juan A Mico
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 4.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

5.  High impulsivity predicts the switch to compulsive cocaine-taking.

Authors:  David Belin; Adam C Mar; Jeffrey W Dalley; Trevor W Robbins; Barry J Everitt
Journal:  Science       Date:  2008-06-06       Impact factor: 47.728

6.  Different affective response to opioid withdrawal in adolescent and adult mice.

Authors:  Stephen R Hodgson; Rebecca S Hofford; Paul J Wellman; Shoshana Eitan
Journal:  Life Sci       Date:  2008-11-12       Impact factor: 5.037

Review 7.  Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.

Authors:  T S Shippenberg; A LeFevour; V I Chefer
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

8.  Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates.

Authors:  Christina S Barr; Melanie L Schwandt; Stephen G Lindell; J Dee Higley; Dario Maestripieri; David Goldman; Stephen J Suomi; Markus Heilig
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

Review 9.  Animal models and treatments for addiction and depression co-morbidity.

Authors:  Neil E Paterson; Athina Markou
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

10.  Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task.

Authors:  Mary C Olmstead; Abdel-Mouttalib Ouagazzal; Brigitte L Kieffer
Journal:  PLoS One       Date:  2009-02-09       Impact factor: 3.240

View more
  44 in total

Review 1.  Time to connect: bringing social context into addiction neuroscience.

Authors:  Markus Heilig; David H Epstein; Michael A Nader; Yavin Shaham
Journal:  Nat Rev Neurosci       Date:  2016-06-09       Impact factor: 34.870

Review 2.  Signalling in response to sub-picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity.

Authors:  Srgjan Civciristov; Michelle L Halls
Journal:  Br J Pharmacol       Date:  2019-04-05       Impact factor: 8.739

3.  A role for the mu opioid receptor in the antidepressant effects of buprenorphine.

Authors:  Shivon A Robinson; Rebecca L Erickson; Caroline A Browne; Irwin Lucki
Journal:  Behav Brain Res       Date:  2016-11-03       Impact factor: 3.332

4.  Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users.

Authors:  Sara L Kroll; Emilija Nikolic; Franziska Bieri; Michael Soyka; Markus R Baumgartner; Boris B Quednow
Journal:  Psychopharmacology (Berl)       Date:  2018-10-11       Impact factor: 4.530

Review 5.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 6.  In vivo opioid receptor heteromerization: where do we stand?

Authors:  D Massotte
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 7.  Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.

Authors:  Chris P Bailey; Stephen M Husbands
Journal:  Expert Opin Drug Discov       Date:  2014-09-25       Impact factor: 6.098

8.  δ-Opioid receptors in the accumbens shell mediate the influence of both excitatory and inhibitory predictions on choice.

Authors:  Vincent Laurent; Felix L Wong; Bernard W Balleine
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

9.  Dissociation of heroin-induced emotional dysfunction from psychomotor activation and physical dependence among inbred mouse strains.

Authors:  G Ayranci; K Befort; L Lalanne; B L Kieffer; P-E Lutz
Journal:  Psychopharmacology (Berl)       Date:  2014-12-09       Impact factor: 4.530

Review 10.  Alcohol and violence: neuropeptidergic modulation of monoamine systems.

Authors:  Klaus A Miczek; Joseph F DeBold; Lara S Hwa; Emily L Newman; Rosa M M de Almeida
Journal:  Ann N Y Acad Sci       Date:  2015-08-18       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.